Barrier dysfunction and bacterial uptake in the follicle-associated epithelium of ileal Crohn's disease

Annals of the New York Academy of Sciences

Volumn 1258, Issue 1, 2012, Pages 125-134

  Keita, Åsa V ^a   Söderholm, Johan D ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of Clinical Immunology and Transfusion Medicine   (Sweden)

Author keywords

Adherent invasive E. coli; Etiology; Inflammatory bowel disease; Pathogens; Peyer's patches

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN;

ARTICLE; BACTERIAL TRANSLOCATION; CROHN DISEASE; ENTEROPATHOGENIC ESCHERICHIA COLI; ENVIRONMENTAL FACTOR; FOLLICLE ASSOCIATED EPITHELIUM; GENETIC PREDISPOSITION; HEREDITY; HUMAN; ILEUM DISEASE; INFLAMMATION; INTESTINE BARRIER DYSFUNCTION; INTESTINE FLORA; LYMPH FOLLICLE; MUCOSAL IMMUNITY; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; PATHOPHYSIOLOGY; PEYER PATCH; SMALL INTESTINE MUCOSA; YERSINIA PSEUDOTUBERCULOSIS;

BACTERIA (MICROORGANISMS);

EID: 84862896140     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06502.x     Document Type: Article

References (82)

1. Keita, A.V. & J.D. Soderholm 2010. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil. 22: 718-733.
2. Bjarnason, I., A. MacPherson & D. Hollander 1995. Intestinal permeability: an overview. Gastroenterology 108: 1566-1581.
3. Salim, S.Y. & J.D. Soderholm 2011. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm. Bowel Dis. 17: 362-381.
4. Vermeire, S., G. van Assche & P. Rutgeerts 2007. Review article: altering the natural history of Crohn's disease-evidence for and against current therapies. Aliment. Pharmacol. Ther. 25: 3-12.
5. Podolsky, D.K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347: 417-429.
6. Duchmann, R. et al 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102: 448-455.
7. Macpherson, A. et al 1996. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38: 365-375.
8. Eckmann, L. 2006. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann. N.Y. Acad. Sci. 1072: 28-38.
9. Bhan, A.K. et al 1999. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol. Rev. 169: 195-207.
10. Cho, J.H. & S.R. Brant 2011. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 140: 1704-1712.
11. Meddings, J.B. 1997. Review article: intestinal permeability in Crohn's disease. Aliment. Pharmacol. Ther. 11(Suppl. 3): 47-53.
12. Hollander, D. 1992. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand. J. Gastroenterol. 27: 721-726.
13. Hugot, J.P. et al 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
14. Pasare, C. & R. Medzhitov 2005. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560: 11-18.
15. Stappenbeck, T.S. et al 2011. Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy 7: 355-374.
16. Barrett, J.C. et al 2008. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40: 955-962.
17. McCarroll, S.A. et al 2008. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet. 40: 1107-1112.
18. Kuballa, P. et al 2008. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS One 3: e3391.
19. Wehkamp, J. et al 2004. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53: 1658-1664.
20. Cadwell, K. et al 2008. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456: 259-263.
21. Kaser, A. et al 2008. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134: 743-756.
22. Vermeire, S. 2004. DLG5 and OCTN. Inflamm. Bowel Dis. 10: 888-890.
23. Buisine, M.P. et al 1999. Abnormalities in mucin gene expression in Crohn's disease. Inflamm. Bowel Dis. 5: 24-32.
24. Kyo, K. et al 2001. Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease. J. Hum. Genet. 46: 5-20.
25. Soderholm, J.D. et al 1999. Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease? Gastroenterology 117: 65-72.
26. Soderholm, J.D. et al 2004. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut 53: 1817-1824.
27. Zeissig, S. et al 2004. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 53: 1295-1302.
28. Sanderson, I.R. & W.A. Walker 1993. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 104: 622-639.
29. Sartor, R.B. 1997. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am. J. Gastroenterol. 92: 5S-11S.
30. Hugot, J.P. et al 2003. Crohn's disease: the cold chain hypothesis. Lancet 362: 2012-2015.
31. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
32. Schurmann, G. et al 1999. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Int. J. Colorectal Dis. 14: 41-46.
33. Zareie, M. et al 2001. Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease. Am. J. Pathol. 158: 1101-1109.
34. Farquhar, M.G. & G.E. Palade 1963. Junctional complexes in various epithelia. J. Cell Biol. 17: 375-412.
35. Hollander, D. et al 1986. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann. Intern. Med. 105: 883-885.
36. Soderholm, J.D. et al 1999. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defense? Gut 44: 96-100.
37. Marin, M.L. et al 1983. A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. Am. J. Gastroenterol. 78: 537-547.
38. Soderholm, J.D. et al 2002. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut 50: 307-313.
39. Zeissig, S. et al 2007. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56: 61-72.
40. Suenaert, P. et al 2002. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am. J. Gastroenterol. 97: 2000-2004.
41. Morson, B.C. 1972. The early histological lesion of Crohn's disease. Proc. R. Soc. Med. 65: 71-72.
42. Van Kruiningen, H.J. et al 2002. Distribution of Peyer's patches in the distal ileum. Inflamm. Bowel. Dis. 8: 180-185.
43. Rutgeerts, P. et al 1984. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 25: 665-672.
44. Rickert, R.R. & H.W. Carter 1980. The "early" ulcerative lesion of Crohn's disease: correlative light- and scanning electron-microscopic studies. J. Clin. Gastroenterol. 2: 11-19.
45. Fujimura, Y., R. Kamoi & M. Iida 1996. Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut 38: 724-732.
46. Gebert, A., H.J. Rothkotter & R. Pabst 1996. M cells in Peyer's patches of the intestine. Int. Rev. Cytol. 167: 91-159.
47. Yamanaka, T. et al 2003. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J. Immunol. 170: 816-822.
48. Gebert, A. 1997. M cells in the rabbit palatine tonsil: the distribution, spatial arrangement and membrane subdomains as defined by confocal lectin histochemistry. Anat. Embryol. (Berl) 195: 353-358.
49. Iwasaki, A. 2007. Mucosal dendritic cells. Annu. Rev. Immunol. 25: 381-418.
50. Neutra, M.R. et al 1999. The composition and function of M cell apical membranes: implications for microbial pathogenesis. Semin. Immunol. 11: 171-181.
51. Neutra, M.R., N.J. Mantis & J.P. Kraehenbuhl 2001. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2: 1004-1009.
52. Kucharzik, T. et al 2000. Characterization of M cell development during indomethacin-induced ileitis in rats. Aliment. Pharmacol. Ther. 14: 247-256.
53. Sanders, D.S. 2005. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease. J. Clin. Pathol. 58: 568-572.
54. Gebert, A. 1997. The role of M cells in the protection of mucosal membranes. Histochem. Cell Biol. 108: 455-470.
55. MacDermott, R.P. & W.F. Stenson 1988. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv. Immunol. 42: 285-328.
56. Macpherson, A.J. & T. Uhr 2004. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303: 1662-1665.
57. Macpherson, A.J., M.B. Geuking & K.D. McCoy 2005. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 115: 153-162.
58. Tamagawa, H. et al 2003. Characteristics of claudin expression in follicle-associated epithelium of Peyer's patches: preferential localization of claudin-4 at the apex of the dome region. Lab. Invest. 83: 1045-1053.
59. Schulte, R. et al 2000. Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell Microbiol. 2: 173-185.
60. Fotopoulos, G. et al 2002. Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc. Natl. Acad. Sci. USA 99: 9410-9414.
61. Sartor, R.B. 1997. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res. Immunol. 148: 567-576.
62. Swidsinski, A. et al 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
63. Neut, C. et al 2002. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am. J. Gastroenterol. 97: 939-946.
64. Ott, S.J. et al 2004. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53: 685-693.
65. Sanderson, J.D. et al 1992. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 33: 890-896.
66. Homewood, R. et al 2003. Ileitis due to Yersinia pseudotuberculosis in Crohn's disease. J. Infect. 47: 328-332.
67. Knosel, T. et al 2009. Prevalence of infectious pathogens in Crohn's disease. Pathol. Res. Pract. 205: 223-230.
68. Darfeuille-Michaud, A. et al 2004. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
69. Martin, H.M. et al 2004. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127: 80-93.
70. Kleessen, B. et al 2002. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 37: 1034-1041.
71. Keita, A.V. et al 2008. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. J. Pathol. 215: 135-144.
72. Salim, S.Y. et al 2009. CD83+CCR7- dendritic cells accumulate in the subepithelial dome and internalize translocated Escherichia coli HB101 in the Peyer's patches of ileal Crohn's disease. Am. J. Pathol. 174: 82-90.
73. Boudeau, J. et al 1999. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun. 67: 4499-509.
74. Darfeuille-Michaud, A. et al 1998. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115: 1405-1413.
75. Barnich, N. et al 2007. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J. Clin. Invest. 117: 1566-1574.
76. Chassaing, B. et al 2011. Crohn disease-associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J. Clin. Invest. 121: 966-975.
77. Denizot, J. et al 2012 Adherent-invasive Escherichia coli induce claudin-2 expression and barrier defect in CEABAC10 mice and Crohn's disease patients. Inflamm. Bowel Dis. 18: 294-304.
78. Furuse, M. et al 2001. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol. 153: 263-272.
79. Ghosh, D. et al 2002. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3: 583-590.
80. Wehkamp, J. et al 2005. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102: 18129-18134.
81. Elphick, D., S. Liddell & Y.R. Mahida 2008. Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin. Am. J. Pathol. 172: 702-713.
82. Wehkamp, J. et al 2007. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J. Immunol. 179: 3109-3118.